Treatment

Cibinqo 100 mg film-coated tablets clinical trials

2 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic confirmatory (Phase III)
B7451015 - A PHASE 3 MULTICENTER, LONG-TERM EXTENSION STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ABROCITINIB, WITH OR WITHOUT TOPICAL MEDICATIONS ADMINISTERED TO SUBJECTS AGED 12 YEARS AND OLDER WITH MODERATE TO SEVERE ATOPIC DERMATITIS
This study looks at a medicine called Abrocitinib (also known as Cibinqo) for people aged 12 and over with moderate to severe eczema. It wants to see if the medicine works well and is safe over a long time, sometimes used with regular skin creams.
For: Moderate to severe atopic dermatitis
Poland · Hungary · Spain
Ongoing, recruitingTherapeutic exploratory (Phase II)
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Abrocitinib in Subjects with Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy
This study is looking at a new medicine called Cibinqo for people with long-lasting, moderate to severe hand eczema that hasn't improved with other treatments. It aims to see if the medicine is safe and effective in reducing symptoms.
For: Moderate to severe chronic hand eczema
Poland